InvestorsHub Logo

Slojab

04/06/16 7:12 PM

#19901 RE: Slojab #19900

If you haven't done the math, 30M shares after a 1:30000 R/S has a value of $90,000,000.

Slojab

04/06/16 7:15 PM

#19902 RE: Slojab #19900

The rights, title and interest of the Injex needleless injector appears to be in dispute with the German manufacturer.

in consideration for 8687544's rights title and interest to a needle free injector system. Including the following rights and assets: A. Design, Specifications and Intellectual Properties of the Needle Free Injector System 505 (for injection of 0.5ml, both reusable and disposable), and One30 (a disposable injection of 0.3). B. Regulatory Approvals for the Needle Free Injector (FDA, Health Canada and European). FDA Version Number – M GBA EN FR R01 1209SFR C. Any and all marketing materials, presentation, clinical trials, research. Including brand name use. D. Any and All Global Rights and Ownership to the Needle Free Injector System and technology referred to as Injex and or its equivalent Generic IP, including but not limited to its designs, its technical know-how, and trade secrets.

I've yet to receive any response from Oda concerning this.